News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,878 Results
Type
Article (46607)
Company Profile (316)
Press Release (688955)
Multimedia
Podcasts (95)
Webinars (12)
Section
Business (214363)
Career Advice (2306)
Deals (37486)
Drug Delivery (117)
Drug Development (84996)
Employer Resources (181)
FDA (16895)
Job Trends (15762)
News (363615)
Policy (34880)
Tag
Academia (2735)
Academic (1)
Accelerated approval (5)
Adcomms (26)
Allergies (91)
Alliances (52657)
ALS (95)
Alzheimer's disease (1425)
Antibody-drug conjugate (ADC) (144)
Approvals (16881)
Artificial intelligence (280)
Autoimmune disease (27)
Automation (16)
Bankruptcy (380)
Best Places to Work (11952)
BIOSECURE Act (21)
Biosimilars (118)
Biotechnology (198)
Bladder cancer (80)
Brain cancer (29)
Breast cancer (286)
Cancer (2352)
Cardiovascular disease (194)
Career advice (1922)
Career pathing (34)
CAR-T (163)
Cell therapy (447)
Cervical cancer (20)
Clinical research (69041)
Collaboration (879)
Company closure (1)
Compensation (548)
Complete response letters (28)
COVID-19 (2737)
CRISPR (47)
C-suite (252)
Cystic fibrosis (104)
Data (2238)
Decentralized trials (2)
Denatured (30)
Depression (49)
Diabetes (289)
Diagnostics (6551)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (126)
Drug pricing (122)
Drug shortages (32)
Duchenne muscular dystrophy (97)
Earnings (89218)
Editorial (43)
Employer branding (22)
Employer resources (155)
Events (117687)
Executive appointments (751)
FDA (18191)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (777)
Gene editing (115)
Generative AI (25)
Gene therapy (330)
GLP-1 (806)
Government (4670)
Grass and pollen (5)
Guidances (67)
Healthcare (19450)
Huntington's disease (24)
IgA nephropathy (31)
Immunology and inflammation (136)
Indications (30)
Infectious disease (2891)
Inflammatory bowel disease (148)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (99)
Interviews (370)
IPO (17030)
IRA (48)
Job creations (4230)
Job search strategy (1641)
Kidney cancer (11)
Labor market (38)
Layoffs (513)
Leadership (24)
Legal (8641)
Liver cancer (77)
Lung cancer (332)
Lymphoma (158)
Machine learning (7)
Management (63)
Manufacturing (331)
MASH (72)
Medical device (13666)
Medtech (13671)
Mergers & acquisitions (21008)
Metabolic disorders (761)
Multiple sclerosis (85)
NASH (21)
Neurodegenerative disease (103)
Neuropsychiatric disorders (33)
Neuroscience (2003)
NextGen: Class of 2025 (6850)
Non-profit (4678)
Now hiring (39)
Obesity (413)
Opinion (254)
Ovarian cancer (77)
Pain (98)
Pancreatic cancer (84)
Parkinson's disease (157)
Partnered (21)
Patents (244)
Patient recruitment (114)
Peanut (50)
People (60544)
Pharmaceutical (98)
Pharmacy benefit managers (21)
Phase I (21464)
Phase II (30317)
Phase III (22749)
Pipeline (1239)
Policy (161)
Postmarket research (2739)
Preclinical (9105)
Press Release (69)
Prostate cancer (109)
Psychedelics (31)
Radiopharmaceuticals (256)
Rare diseases (411)
Real estate (6454)
Recruiting (69)
Regulatory (23784)
Reports (47)
Research institute (2458)
Resumes & cover letters (382)
Rett syndrome (5)
RNA editing (5)
RSV (49)
Schizophrenia (78)
Series A (134)
Series B (87)
Service/supplier (15)
Sickle cell disease (55)
Special edition (17)
Spinal muscular atrophy (154)
Sponsored (30)
Startups (3859)
State (2)
Stomach cancer (15)
Supply chain (75)
Tariffs (46)
The Weekly (63)
Vaccines (742)
Venture capitalists (41)
Weight loss (290)
Women's health (36)
Worklife (18)
Date
Today (50)
Last 7 days (914)
Last 30 days (2664)
Last 365 days (33733)
2025 (11121)
2024 (36345)
2023 (41179)
2022 (52380)
2021 (56996)
2020 (55560)
2019 (48480)
2018 (36666)
2017 (34025)
2016 (33726)
2015 (39549)
2014 (33435)
2013 (28592)
2012 (30712)
2011 (31378)
2010 (29344)
Location
Africa (843)
Alabama (53)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (42499)
Australia (6862)
California (6204)
Canada (2038)
China (552)
Colorado (272)
Connecticut (277)
Delaware (153)
Europe (92343)
Florida (930)
Georgia (214)
Idaho (58)
Illinois (566)
India (27)
Indiana (327)
Iowa (11)
Japan (168)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (924)
Massachusetts (4674)
Michigan (225)
Minnesota (399)
Mississippi (2)
Missouri (83)
Montana (27)
Nebraska (25)
Nevada (64)
New Hampshire (63)
New Jersey (1764)
New Mexico (31)
New York (1772)
North Carolina (1033)
North Dakota (8)
Northern California (2702)
Ohio (207)
Oklahoma (14)
Oregon (40)
Pennsylvania (1395)
Puerto Rico (13)
Rhode Island (33)
South America (1220)
South Carolina (24)
South Dakota (1)
Southern California (2322)
Tennessee (103)
Texas (923)
United States (23642)
Utah (184)
Virginia (157)
Washington D.C. (63)
Washington State (565)
West Virginia (3)
Wisconsin (57)
735,878 Results for "catalyst pharma group inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES LAUNCH OF AUTHORIZED GENERIC OF Maxitrol® (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension)
April 25, 2025
·
3 min read
Press Releases
Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan
January 21, 2025
·
4 min read
Press Releases
LSL PHARMA GROUP REPORTS ITS FOURTH QUARTER AND YEAR-END 2024 RESULTS
May 2, 2025
·
11 min read
Press Releases
Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025
April 30, 2025
·
2 min read
Press Releases
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), PRESENTING PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING
April 24, 2025
·
4 min read
Press Releases
Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025
April 23, 2025
·
2 min read
Press Releases
LSL PHARMA GROUP ANNOUNCES THE SIGNING OF TWO AGREEMENTS TO MARKET NEW OPHTHALMIC PRODUCTS IN CANADA
April 3, 2025
·
1 min read
Press Releases
Precision Medicine Group Names Pharma Services Innovator, Eric Hodgins, as Chief Information and Technology Officer
April 16, 2025
·
3 min read
Business
Five Biggest Drug Face-Offs in Pharma History
Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of rivalry that includes blockbuster drugs Keytruda, Humira and Eliquis.
April 9, 2025
·
9 min read
·
Tristan Manalac
LSL Pharma Group Completes the Acquisition of Virage Santé
LSL PHARMA GROUP INC., a Canadian integrated pharmaceutical company, is pleased to announce the completion of the acquisition of Virage Santé, a company specializing in the manufacturing and marketing of natural health products, based in Lévis, Quebec.
June 18, 2024
·
3 min read
1 of 73,588
Next
